Treatment of End-Stage Hallux Rigidus Using Total Joint Arthroplasty: A Short-Term Clinical Study.

J Foot Ankle Surg

Assistant Professor, Orthopaedics and Traumatology Department, Dumlupinar University School of Medicine, Kutahya, Turkey.

Published: June 2018

The treatment of advanced hallux rigidus remains controversial. Only a few studies have analyzed the short- and mid-term results of metatarsophalangeal (MTP) joint arthroplasty to treat patients with advanced hallux rigidus. We present the short-term follow-up results of patients who underwent MTP joint arthroplasty. We reviewed the medical records of 15 consecutive patients (3 males and 12 females) who had had grade 3 or 4 hallux rigidus diagnosed according to the Coughlin and Shurnas classification. The age range at surgery was 44 to 74 (mean 61.6) years. The mean follow-up period was 21.7 (range 18 to 28) months. The mean change in the overall American Orthopaedic Foot and Ankle Society Hallux-First Ray scale score was from 26.9 ± 2.3 preoperatively to 78.7 ± 8.8 postoperatively (p < .005). The mean change in the overall visual analog scale score was from 8.3 ± 0.8 preoperatively to 1.7 ± 0.7 postoperatively (p < .005). The mean preoperative first MTP joint range of motion was 22.3° ± 7.7° (range 15° to 45°), which had increased to 77° (range 65° to 90°) at the final follow-up visit. No patient required revision surgery or removal. These results indicate that for patients with advanced-stage hallux rigidus refractory to conservative treatment, total joint arthroplasty can lead to good satisfaction and good functional results in the short term.

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.jfas.2017.05.017DOI Listing

Publication Analysis

Top Keywords

hallux rigidus
16
joint arthroplasty
12
advanced hallux
8
mtp joint
8
treatment end-stage
4
hallux
4
end-stage hallux
4
rigidus
4
rigidus total
4
total joint
4

Similar Publications

Range of Flexion Improvement in Degenerative Stages of the First Metatarsophalangeal Joint () with Cross-Linked Hyaluronic Acid: A Cadaveric Study.

J Funct Morphol Kinesiol

December 2024

Human Anatomy and Embryology Unit, Experimental Pathology and Therapeutics Department, Faculty of Medicine and Health Sciences, University of Barcelona, 08907 Hospitalet, Spain.

Background: Viscosupplementation consists of intraarticular hyaluronic acid injections applied to treat pain and improve joint mobility. The objective of the study was to analyze the improvement of the range of mobility of the first metatarsophalangeal joint with a single dose of cross-linked hyaluronic acid.

Methods: Ten fresh frozen specimens of feet sectioned below the knee were selected.

View Article and Find Full Text PDF

Background: Minimally invasive cheilectomy is becoming a more prominent surgical approach in the management of mild to moderate hallux rigidus. This systematic review aims to analyze and present the current literature on patient-reported outcomes following minimally invasive (MIS) cheilectomy for mild to moderate hallux rigidus.

Methods: PubMed, Cochrane Central Register of Controlled Trials, and Scopus databases were searched in April 2024.

View Article and Find Full Text PDF

Cheilectomy is a joint-sparing surgery for the treatment of moderate stages of Hallux Rigidus (HR). The purpose of this systematic review was to assess the clinical outcomes, range of motion (ROM), complications, and revision rates associated with cheilectomy. A literature search of the PubMed, Scopus, and Cochrane databases was performed.

View Article and Find Full Text PDF

Background: To investigate the impact of decompressive chevron osteotomy on subchondral bone density at the first metatarsophalangeal (MTP) joint.

Methods: Sixteen feet (12 patients) with hallux rigidus underwent decompressive chevron osteotomy. Standing cone beam 3D computed tomography (3DCT) were assessed preoperatively and at 4-month follow-up, and clinical data were collected.

View Article and Find Full Text PDF
Article Synopsis
  • The study assesses the effectiveness of the Cartiva synthetic cartilage implant for treating severe osteoarthritis in the first metatarsophalangeal joint, aiming to provide pain relief and maintain joint mobility compared to traditional arthrodesis.
  • Researchers reviewed outcomes from 64 patients, focusing on various patient-reported outcome measures (PROMs) to evaluate functional improvement over a three-year period post-surgery.
  • Results indicated significant enhancements in PROMs for most patients, although one individual experienced an infection related to the implant.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!